AiBST as a partner in the GHP Programme, CPA and CPA Plus
AiBST is partner in the Global Health Protection Programme in which it works with the Federal Institute for Drugs and Medical Devices (BfArM) on the project “Combating Resistance in the Treatment of Infectious Diseases by Promoting Judicious/Rational Use of Anti-infective Drugs” .
CPA facilitates collaborative research on optimal use of anti-infective drugs as a means to combat antimicrobial resistance.
The research projects under CPA will help fill important gaps in knowledge about locally-relevant, real-world hospital practice and ways in which scientific training on appropriate drug use may assist healthcare professionals optimize/increase benefits to the individual patient alongside promoting public health.
Three PhD students from Zimbabwe, Zambia and Malawi will conduct research in the fields of drug safety, clinical pharmacology, pharmacogenetics and individualized therapy. The project will enable a situation analysis of prescription practices and resistance in healthcare facilities and strengthen transfer of knowledge on optimal and judicious use of anti-infective drugs.
For more information, follow this link https://ghpp.de/en/projects/cpa-and-cpa-plus/